DK0814790T3 - Indgivelse af ketamin med henblik på afgiftning - Google Patents

Indgivelse af ketamin med henblik på afgiftning

Info

Publication number
DK0814790T3
DK0814790T3 DK96906452T DK96906452T DK0814790T3 DK 0814790 T3 DK0814790 T3 DK 0814790T3 DK 96906452 T DK96906452 T DK 96906452T DK 96906452 T DK96906452 T DK 96906452T DK 0814790 T3 DK0814790 T3 DK 0814790T3
Authority
DK
Denmark
Prior art keywords
ketamine
administration
present
substance addiction
treatment
Prior art date
Application number
DK96906452T
Other languages
Danish (da)
English (en)
Inventor
Stuart L Weg
Original Assignee
Stuart L Weg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1995/002418 external-priority patent/WO1995022965A2/en
Priority claimed from US08/477,365 external-priority patent/US5679714A/en
Application filed by Stuart L Weg filed Critical Stuart L Weg
Application granted granted Critical
Publication of DK0814790T3 publication Critical patent/DK0814790T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK96906452T 1995-02-24 1996-02-14 Indgivelse af ketamin med henblik på afgiftning DK0814790T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US1995/002418 WO1995022965A2 (en) 1994-02-25 1995-02-24 Nasal and ocular administration of ketamine to manage pain and for detoxification
US08/477,365 US5679714A (en) 1995-06-07 1995-06-07 Administration of ketamine for detoxification and treatment of tobacco addiction
PCT/US1996/002047 WO1996025925A1 (en) 1995-02-24 1996-02-14 Nasal and ocular administration of ketamine to manage pain and for detoxification

Publications (1)

Publication Number Publication Date
DK0814790T3 true DK0814790T3 (da) 2003-11-10

Family

ID=26789531

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96906452T DK0814790T3 (da) 1995-02-24 1996-02-14 Indgivelse af ketamin med henblik på afgiftning

Country Status (9)

Country Link
EP (1) EP0814790B1 (ja)
JP (1) JP4173538B2 (ja)
AT (1) ATE245024T1 (ja)
AU (1) AU733284B2 (ja)
CA (1) CA2213567C (ja)
DE (1) DE69629108T2 (ja)
DK (1) DK0814790T3 (ja)
ES (1) ES2205018T3 (ja)
WO (1) WO1996025925A1 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014152196A1 (en) 2013-03-15 2014-09-25 Janssen Pharmaceutica Nv Pharmaceutical composition of s-ketamine hydrochloride
CN107208133A (zh) 2014-09-15 2017-09-26 詹森药业有限公司 用于治疗抑郁症的Val66Met (SNPrs6265)基因型特异性给药方案和方法
US10179136B2 (en) 2015-06-19 2019-01-15 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
US20200297734A1 (en) 2015-06-19 2020-09-24 Melt Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
US10391102B2 (en) 2015-06-19 2019-08-27 Melt Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
US10166240B2 (en) 2015-06-19 2019-01-01 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
KR101964571B1 (ko) * 2015-06-19 2019-04-02 해로우 헬스 인코포레이티드 마취용 약학 조성물
US10555952B2 (en) 2015-06-19 2020-02-11 Melt Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
US20200009081A1 (en) 2017-09-13 2020-01-09 Janssen Pharmaceutica N.V. Delivery Of Esketamine For The Treatment Of Depression
SG11202005896WA (en) 2017-12-22 2020-07-29 Janssen Pharmaceuticals Inc Esketamine for the treatment of depression
PL3505157T3 (pl) * 2017-12-29 2022-04-11 Celon Pharma S.A. Kompozycja ketaminy w postaci suchego proszku do podawania dopłucnego w leczeniu depresji opornej na leczenie
MX2021010683A (es) 2019-03-05 2021-12-10 Janssen Pharmaceuticals Inc Esketamina para el tratamiento de la depresión.
WO2023207729A1 (zh) * 2022-04-26 2023-11-02 宜昌人福药业有限责任公司 艾司氯胺酮液体制剂及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
US5543434A (en) * 1994-02-25 1996-08-06 Weg; Stuart L. Nasal administration of ketamine to manage pain

Also Published As

Publication number Publication date
EP0814790A1 (en) 1998-01-07
JP4173538B2 (ja) 2008-10-29
CA2213567C (en) 2010-01-26
ES2205018T3 (es) 2004-05-01
DE69629108D1 (de) 2003-08-21
AU4982796A (en) 1996-09-11
AU733284B2 (en) 2001-05-10
ATE245024T1 (de) 2003-08-15
DE69629108T2 (de) 2004-04-22
WO1996025925A1 (en) 1996-08-29
JPH11500729A (ja) 1999-01-19
CA2213567A1 (en) 1996-08-29
EP0814790B1 (en) 2003-07-16

Similar Documents

Publication Publication Date Title
DK0814790T3 (da) Indgivelse af ketamin med henblik på afgiftning
MX9603633A (es) Administracion nasal y ocular de ketamina para manejar el dolor y para la detoxificacion.
ATE276676T1 (de) Zusammensetzung zur reduzierung oder entwöhnung von nikotinabhängigkeit
NO20060913L (no) Behandling av avhengighetsabstinens
CA1152003A (en) Means and method for aiding individuals to stop smoking
MY127739A (en) Use of pramipexole for the treatment of addictive disorders
HUP0300048A2 (hu) Transzdermális vagy transzmukozális dohányzásról leszoktató készítmények, melyek nikotintartalmú hatóanyagkombinációt tartalmaznak és alkalmazásuk
DK0863760T3 (da) Anvendelse af forbindelser med antimineralcorticoid virkning over for narkotikafvænning
EA004184B1 (ru) Способ уменьшения или прекращения курения
UA27884C2 (uk) Засіб для лікування розладів, викликаних зловживанням ліками та спосіб лікування або профілактики зазначеним засобом абстинентного синдрому
ATE301462T1 (de) Verwendung von reboxetine zur behandlung neuropsychiatrischer beschwerden
MX9706456A (es) Administracion nasal y ocular de la cetamina para manejar el dolor y para la destoxificacion.
BR9908190A (pt) Processos para tratar a dor especìfica de fêmea em um paciente fêmea, e para tratar a dor crÈnica em um paciente
Richmond et al. Controlled Trial of the 24-Hour Transdermal Nicotine Patch in Conjunction With Cognitive-Behavioural Therapy: 6-Months’ Results
JP2004505053A (ja) 喫煙の減少または解消方法
SU1537259A1 (ru) Средство, подавл ющее влечение к никотину и табачному дыму
Hendrie Alternative strategies and new treatments for smoking
MY142346A (en) Medicament and method for reducing alcohol and/or tobacco consumption
PROTOCOL Western Regional Emergency Medical Advisory Committee
Radzius et al. Cigarette Smoking not Affected by Cocaine Self-Administration
UA42352A (uk) Спосіб лікування хронічного гастродуоденіту із супутніми захворюваннями внутрішніх органів